Literature DB >> 22646737

KCa 3.1 channels maintain endothelium-dependent vasodilatation in isolated perfused kidneys of spontaneously hypertensive rats after chronic inhibition of NOS.

Serge Simonet1, Marc Isabelle, Mélanie Bousquenaud, Nicolas Clavreul, Michel Félétou, Christine Vayssettes-Courchay, Tony J Verbeuren.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of the study was to investigate renal endothelium-dependent vasodilatation in a model of severe hypertension associated with kidney injury. EXPERIMENTAL APPROACH: Changes in perfusion pressure were measured in isolated, perfused kidneys taken from 18-week-old Wistar-Kyoto rat (WKY), spontaneously hypertensive rats (SHR) and SHR treated for 2 weeks with N(ω) -nitro-L-arginine methyl ester in the drinking water (L-NAME-treated SHR, 6 mg·kg(-1) ·day(-1) ). KEY
RESULTS: Acetylcholine caused similar dose-dependent renal dilatation in the three groups. In vitro administration of indomethacin did not alter the vasodilatation, while the addition of N(w) -nitro-L-arginine (L-NA) produced a differential inhibition of the vasodilatation, (inhibition in WKY > SHR > L-NAME-treated SHR). Further addition of ODQ, an inhibitor of soluble guanylyl cyclase, abolished the responses to sodium nitroprusside but did not affect the vasodilatation to acetylcholine. However, the addition of TRAM-34 (or charybdotoxin) inhibitors of Ca(2+) -activated K(+) channels of intermediate conductance (K(Ca) 3.1), blocked the vasodilatation to acetylcholine, while apamin, an inhibitor of Ca(2+) -activated K(+) channels of small conductance (K(Ca) 2.3), was ineffective. Dilatation induced by an opener of K(Ca) 3.1/K(Ca) 2.3 channels, NS-309, was also blocked by TRAM-34, but not by apamin. The magnitude and duration of NS-309-induced vasodilatation and the renal expression of mRNA for K(Ca) 3.1, but not K(Ca) 2.3, channels followed the same ranking order (WKY < SHR < L-NAME-treated SHR). CONCLUSIONS AND IMPLICATIONS: In SHR kidneys, an EDHF-mediated response, involving activation of K(Ca) 3.1 channels, contributed to the mechanism of endothelium-dependent vasodilatation. In kidneys from L-NAME-treated SHR, up-regulation of this pathway fully compensated for the decrease in NO availability.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22646737      PMCID: PMC3575784          DOI: 10.1111/j.1476-5381.2012.02062.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  69 in total

1.  Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney.

Authors:  D Fulton; J C McGiff; J Quilley
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

2.  Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats.

Authors:  H Ono; Y Ono; A Takanohashi; H Matsuoka; E D Frohlich
Journal:  Hypertension       Date:  2001-12-01       Impact factor: 10.190

3.  Selective blockade of endothelial Ca2+-activated small- and intermediate-conductance K+-channels suppresses EDHF-mediated vasodilation.

Authors:  Ines Eichler; Judith Wibawa; Ivica Grgic; Andrea Knorr; Susanne Brakemeier; Axel R Pries; Joachim Hoyer; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

4.  Pitavastatin inhibits upregulation of intermediate conductance calcium-activated potassium channels and coronary arteriolar remodeling induced by long-term blockade of nitric oxide synthesis.

Authors:  Yutaka Terata; Takashi Saito; Yoshimasa Fujiwara; Hitoshi Hasegawa; Hiroto Miura; Hiroyuki Watanabe; Yoshikatsu Chiba; Satoshi Kibira; Mamoru Miura
Journal:  Pharmacology       Date:  2003-08       Impact factor: 2.547

5.  Mechanisms for altered endothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats.

Authors:  H Hayakawa; Y Hirata; E Suzuki; T Sugimoto; H Matsuoka; K Kikuchi; T Nagano; M Hirobe; T Sugimoto
Journal:  Am J Physiol       Date:  1993-05

6.  Effect of vasodilators, including nitric oxide, on the release of cGMP and cAMP in the isolated perfused rat kidney.

Authors:  I Heuzé-Joubert; P Mennecier; S Simonet; M Laubie; T J Verbeuren
Journal:  Eur J Pharmacol       Date:  1992-09-22       Impact factor: 4.432

7.  Mechanisms of the increased pressor response to vasopressors in the mesenteric bed of nitric oxide-deficient hypertensive rats.

Authors:  F M Ruiz-Marcos; M C Ortíz; L A Fortepiani; F J Nadal; N M Atucha; J García-Estañ
Journal:  Eur J Pharmacol       Date:  2001-02-02       Impact factor: 4.432

8.  Endothelial dilatory function predicts individual susceptibility to renal damage in the 5/6 nephrectomized rat.

Authors:  Simone Gschwend; Hendrik Buikema; Gerjan Navis; Robert H Henning; Dick de Zeeuw; Richard P E van Dokkum
Journal:  J Am Soc Nephrol       Date:  2002-12       Impact factor: 10.121

9.  Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.

Authors:  J A Panza; C E García; C M Kilcoyne; A A Quyyumi; R O Cannon
Journal:  Circulation       Date:  1995-03-15       Impact factor: 29.690

10.  Vasodilation to acetylcholine in primary and secondary forms of human hypertension.

Authors:  S Taddei; A Virdis; P Mattei; A Salvetti
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

View more
  9 in total

Review 1.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

2.  Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure.

Authors:  Ludovic Waeckel; Florence Bertin; Nicolas Clavreul; Thibaut Damery; Ralf Köhler; Jérôme Paysant; Patricia Sansilvestri-Morel; Serge Simonet; Christine Vayssettes-Courchay; Heike Wulff; Tony J Verbeuren; Michel Félétou
Journal:  Pflugers Arch       Date:  2014-06-07       Impact factor: 3.657

3.  Contribution of K(+) channels to endothelium-derived hypolarization-induced renal vasodilation in rats in vivo and in vitro.

Authors:  Kasper Moller Boje Rasmussen; Thomas Hartig Braunstein; Max Salomonsson; Jens Christian Brasen; Charlotte Mehlin Sorensen
Journal:  Pflugers Arch       Date:  2016-03-11       Impact factor: 3.657

4.  Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice.

Authors:  Josephine Radtke; Kjestine Schmidt; Heike Wulff; Ralf Köhler; Cor de Wit
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

5.  Vascular Reactivity Profile of Novel KCa 3.1-Selective Positive-Gating Modulators in the Coronary Vascular Bed.

Authors:  Aida Oliván-Viguera; Marta Sofía Valero; Estéfano Pinilla; Sara Amor; Ángel Luis García-Villalón; Nichole Coleman; Celia Laría; Víctor Calvín-Tienza; Ángel-Luis García-Otín; José M Fernández-Fernández; M Divina Murillo; José A Gálvez; María D Díaz-de-Villegas; Ramón Badorrey; Ulf Simonsen; Luis Rivera; Heike Wulff; Ralf Köhler
Journal:  Basic Clin Pharmacol Toxicol       Date:  2016-02-29       Impact factor: 4.080

Review 6.  Endothelium-Dependent Hyperpolarization (EDH) in Hypertension: The Role of Endothelial Ion Channels.

Authors:  Kenichi Goto; Toshio Ohtsubo; Takanari Kitazono
Journal:  Int J Mol Sci       Date:  2018-01-21       Impact factor: 5.923

7.  Baroreflex Impairment Precedes Cardiometabolic Dysfunction in an Experimental Model of Metabolic Syndrome: Role of Inflammation and Oxidative Stress.

Authors:  Nathalia Bernardes; Danielle da Silva Dias; Filipe Fernandes Stoyell-Conti; Janaina de Oliveira Brito-Monzani; Christiane Malfitano; Elia Garcia Caldini; Luis Ulloa; Susana Francisca Llesuy; Maria-Cláudia Irigoyen; Kátia De Angelis
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

8.  KCa 3.1 upregulation preserves endothelium-dependent vasorelaxation during aging and oxidative stress.

Authors:  Shinkyu Choi; Ji Aee Kim; Hai-Yan Li; Kyong-Oh Shin; Goo Taeg Oh; Yong-Moon Lee; Seikwan Oh; Yael Pewzner-Jung; Anthony H Futerman; Suk Hyo Suh
Journal:  Aging Cell       Date:  2016-06-30       Impact factor: 9.304

9.  Hypoxia/Reoxygenation of Rat Renal Arteries Impairs Vasorelaxation via Modulation of Endothelium-Independent sGC/cGMP/PKG Signaling.

Authors:  Diana Braun; Christa Zollbrecht; Stefanie Dietze; Rudolf Schubert; Stefan Golz; Holger Summer; Pontus B Persson; Mattias Carlström; Marion Ludwig; Andreas Patzak
Journal:  Front Physiol       Date:  2018-05-03       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.